For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.
Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).
Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).
Scope of the Report:
This report focuses on the Microbial Fermentation APIs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With developed pharmaceuticals industry, Europe, USA and Japan are the major consumption markets of microbial fermentation APIs. These international pharmaceuticals giants generally purchase APIs from Asia, especially China and India.
China is the emerging consumption market of microbial fermentation APIs and it is also the largest supplier. In the market of antibiotics and vitamin, China have occupied market share of more than half. With foreign based plants and local manufacturers, India is another major supplier of APIs.
Antibiotics enjoyed the largest market share of microbial fermentation APIs, and China is the largest supplier with production of about 150 K MT. Amino acids are another important parts of microbial fermentation APIs market. Among these amino acids, the amount of glutamic acid and l-lysine are at most.
The worldwide market for Microbial Fermentation APIs is expected to grow at a CAGR of roughly 1.8% over the next five years, will reach 30800 million US$ in 2023, from 27700 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- North China Pharmaceutical
- CSPC Pharma
- Northeast Pharm
- Lukang Pharmaceutical
- Luwei Pharmaceutical
- Jiangshan (DSM)
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Amino acids
- Organic acid
- Biological products
Market Segment by Applications, can be divided into
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
There are 15 Chapters to deeply display the global Microbial Fermentation APIs market.
Chapter 1, to describe Microbial Fermentation APIs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Microbial Fermentation APIs, with sales, revenue, and price of Microbial Fermentation APIs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Microbial Fermentation APIs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Microbial Fermentation APIs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Microbial Fermentation APIs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source